Lifespan Respite Care Program: State Grants
- Response deadline
- Jul 22, 2026 Closed
- Date posted
- Jun 22, 2026
- Source
- Open notice
Description
ACL is seeking applications from eligible state agencies that will advance the provision of respite services through their statewide Lifespan Respite Care system as outlined in the Act. There are two application options for states contained in this single Notice of Funding Opportunity. State Applicants for Option A (Grants to New States and States Re-Establishing Their Core Respite Infrastructures): This opportunity is for states who have never had a grant, OR who had a grant before, but the program has stopped, and they wish to start it up again. State Applicants for Option B (State Program Enhancement Grants): This opportunity is intended for states that have had at least one grant in the past and/or wish to continue building and expanding upon their programmatic activities to enhance and expand the availability of lifespan respite services. Grantees will collaborate with state respite organizations and coalitions to enhance and expand the availability of lifespan respite services. The goal of the program is to enhance state systems and capacities to deliver respite care and related services to family caregivers of children and adults across all age groups, disabilities, and chronic conditions.
Classifications
- NAICS93.072
Documents (1)
- Downloadhhs-2026-acl-aoa-lrli-0053-v562626.pdfapplication/pdf331 KB
Contacts
Similar contracts
- Lifespan Respite National Technical Assistance and Resource CenterDue Jul 27, 2026
- Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)Due Mar 5, 2029
- NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)Due May 26, 2027
- Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)Due Jan 10, 2028
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)Due Feb 8, 2028
- NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food SpecimensDue Apr 1, 2027